•
Dec 31, 2014

Jazz Pharmaceuticals Q4 2014 Earnings Report

Total Revenue
$328M
Previous year: $236M
+39.2%
EPS
$2.44
Previous year: $1.72
+41.9%
Gross Profit
$299M
Previous year: $210M
+42.5%
Cash and Equivalents
$684M
Previous year: $637M
+7.5%
Total Assets
$3.34B
Previous year: $2.24B
+49.2%

Jazz Pharmaceuticals

Jazz Pharmaceuticals